Inegy
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Copyright: this is an open access article published under the terms of the Creative Commons License Deed (CC BY-NC-ND 3.0) which…
Ezetimibe is a drug that lowers cholesterol. It acts by decreasing cholesterol absorption in the intestine. It may be used alone…
SummaryBACKGROUND: In patients at risk for cardiovascular complications, established LDL cholesterol (LDL-C) target levels are…
A study linking any substance with cancer can be guaranteed to make the news, even when the news is that the link might not exist…
Inegy, recently launched by Merck Sharp & Dohme and Schering Plough, is a fixed combination of simvastatin, which inhibits…
The latest clinical intervention studies of statins have shown that more aggressive reductions in LDL-cholesterol to values lower…
Inegy is a combination of ezetimibe and simvastatin for use in hypercholesterolaemia. Dr Weston describes the trial results…
Ezetimibe/simvastatin (INEGY™), a dual inhibitor of both cholesterol production and absorption, is a new approach to the…